Accrol Group Holdings plc (the “Company” or “Accrol”), the AIM-listed leading independent tissue converter, notes that the 36,000,000 new ordinary shares issued pursuant to the recently announced Placing to raise £18 million have been admitted to trading earlier today (“Admission”)….